AI & ChatGPT searches , social queriess for BLOSOZUMAB
Search references for BLOSOZUMAB. Phrases containing BLOSOZUMAB
See searches and references containing BLOSOZUMAB!
Search references for BLOSOZUMAB. Phrases containing BLOSOZUMAB
See searches and references containing BLOSOZUMAB!BLOSOZUMAB
Chemical compound
Blosozumab binds SOST, a negative regulator of osteoblast activity. Blocking SOST activity can lead to increased bone density. Blosozaumab has been studied
Blosozumab
Monoclonal antibody against amyloid beta
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Donanemab
Antibodies from clones of the same blood cell
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Monoclonal_antibody
Experimental monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Prasinezumab
Drug class
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Anti-amyloid_antibodies
Pharmaceutical drug
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Evolocumab
Chemical compound
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Bimagrumab
Monoclonal antibody against amyloid beta
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Lecanemab
Human monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Denosumab
Antibodies from non-human species made nearly identical with human ones
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Humanized_antibody
Group of genetic disorders resulting in fragile bones
romosozumab (targets sclerostin, by Amgen), fresolimumab (TGF-β, Sanofi), blosozumab (sclerostin, Lilly), and setrusumab (sclerostin, begun by Novartis). Setrusumab
Osteogenesis_imperfecta
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Emicizumab
Medication
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Bevacizumab
Pharmaceutical drug
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Romosozumab
Pharmaceutical biological monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Fremanezumab
Pharmaceutical compound
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Abciximab
Medication
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Marstacimab
Protein-coding gene in the species Homo sapiens
(February 2015). "A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral
Sclerostin
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Bedinvetmab
Medication
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Concizumab
Chemical compound
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Bococizumab
lymphoblastic leukemia (ALL) (CD19+) Blontuvetmab Blontress mab veterinary CD20 Blosozumab mab humanized SOST osteoporosis Bococizumab mab humanized PCSK9 dyslipidemia
List of therapeutic monoclonal antibodies
List_of_therapeutic_monoclonal_antibodies
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Trevogrumab
Monoclonal antibody medication
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Solanezumab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Ozanezumab
Drugs that inhibit α-synuclein
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Anti-α-synuclein_drug
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Abelacimab
Chemical compound
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Caplacizumab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Galcanezumab
Medication
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Idarucizumab
Monoclonal antibody designed to treat X-linked hypophosphatemia
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Burosumab
INN) Blis-To-Sol (Oakhurst Company) Blocadren (Merck) blonanserin (INN) blosozumab (INN) Bluboro Blujepa bluensomycin (INN) BMS 337039 BMS-232632 boceprevir
List_of_drugs:_Bi–Bo
Monoclonal antibody protein
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Gantenerumab
Chemical compound
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Bapineuzumab
Monoclonal antibody against amyloid beta
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Aducanumab
Veterinary medication
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Izenivetmab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Stamulumab
Pharmaceutical compound
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Amlenetug
Veterinary medication
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Relfovetmab
Pharmaceutical drug
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Alirocumab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Etaracizumab
Chemical compound
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Erenumab
Antibody tested against Alzheimer's
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Crenezumab
Anti-tau monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Semorinemab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Eptinezumab
Pharmaceutical compound
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Devextinetug
Pharmaceutical drug
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Ramucirumab
Medication for macular degeneration
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Faricimab
Chemical compound
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Tanezumab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Inclacumab
Pharmaceutical drug
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Brolucizumab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Evinacumab
Medication
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Bentracimab
Experimental monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Cinpanemab
Pharmaceutical drug
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Ranibizumab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Demcizumab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Opicinumab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Enoticumab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Icrucumab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Rinucumab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Vanucizumab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Fasinumab
Chemical compound
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Fulranumab
Pharmaceutical compound
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Indium_(111In)_imciromab
Pharmaceutical compound
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Indium_(111In)_biciromab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Refanezumab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Orticumab
Chemical compound
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Ascrinvacumab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Ponezumab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Ralpancizumab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Volociximab
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Nesvacumab
Pharmaceutical drug
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Alacizumab_pegol
Monoclonal antibody
circulatory, and neurologic systems Bone Human Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab
Tadocizumab
BLOSOZUMAB
BLOSOZUMAB
BLOSOZUMAB
BLOSOZUMAB
Girl/Female
Latin
Jet black.
Boy/Male
Hindu
Undefeatable
Girl/Female
Indian, Telugu
More Portion
Female
German
Variant spelling of Old High German Adalhaid, ADALHEID means "noble sort."Â
Surname or Lastname
English
English : variant of Northcutt.
Girl/Female
American, British, Celtic, Christian, English
Bird; Songbird; Grace
Girl/Female
Bengali, Indian
Beloved
Boy/Male
English American
Knight.
Girl/Female
Hindu, Indian, Jain
Sweet
Boy/Male
Indian
Beauty of the faith, Beauty of the religion
BLOSOZUMAB
BLOSOZUMAB
BLOSOZUMAB
BLOSOZUMAB
BLOSOZUMAB